Table 2.

Pooled estimates for the prevalence of post-Cryptosporidium sequelae using a random effects model

Sequelae	No. of studies	Pooled estimate (%) (95% CI)	Cochran Q	P-value
Diarrhoea	13	25 (10–44)	1382.71	< 0.001
Abdominal pain	13	25 (13–39)	575.30	< 0.001
Joint pain	13	15 (12–19)	63.28	< 0.001
Fatigue	13	24 (13–37)	477.50	< 0.001
Vomiting	10	8 (5–12)	72.61	< 0.001
Headache	10	21 (12–33)	271.21	< 0.001
Eye pain	10	10 (7–14)	46.66	< 0.001
Loss of appetite	9	19 (14–24)	51.32	< 0.001
Weight loss	9	13 (7–20)	97.98	< 0.001
Nausea	8	24 (11–40)	263.50	< 0.001
Blood in stool	7	3 (2–6)	17.26	0.01
Dizzy spells	6	8 (5–12)	13.24	0.02
Fever	5	13 (4–25)	51.28	< 0.001
Blurred vision	5	6 (4–8)	5.19	0.27
IBS	3	11 (6–16)	0.11	0.95

Note: Studies were included more than once if outcomes were reported at more than one interval